GLUT4 activator3 (Compound 13a) is an antidiabetic agent that targets GLUT4 translocation in skeletal muscle. It facilitates the translocation of glucose transporter 4 (GLUT4) within skeletal muscle cells and effectively reduces blood glucose levels in diabetic rats induced by STZ.
Target-Kategorie:
transporter
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
